Medical Company Expands Collaboration To Treat Mental Disorders
Clearmind Medicine and Yissum intensify their collaboration through an international patent application for the development of Generation 3.0 psychedelic compounds aimed at treating mental disorders.
Disclaimer: The following article provides a detailed overview of Clearmind Medicine's collaboration with Yissum on the international patent application for Generation 3.0 psychedelic compounds. This discussion is intended for informational purposes only and does not constitute medical or legal advice. Readers are encouraged to c…